UK Enforces Indefinite Ban on Puberty Blockers for Minors

The UK has indefinitely banned new prescriptions of puberty blockers for minors with gender dysphoria, following an independent study that highlighted weak medical evidence and potential safety risks. The decision, supported by the study's author, Dr. Hilary Cass, emphasizes the need for evidence-led children's healthcare. Transgender activists have criticized the ban, which allows current users to continue treatment and permits prescriptions for cisgender minors with early puberty. The ban will be reviewed in 2027, as the UK plans clinical trials on the medication.